BUDGET IMPACT OF ORAL PROLONGED-RELEASE FAMPRIDINE FOR MANAGEMENT OF WALKING DISABILITY ASSOCIATED WITH MULTIPLE SCLEROSIS IN TAIWAN

被引：0
|
作者：
Lee-Grossman, C. W. [1 ]
Alexopoulos, S. T. [2 ]
Murphy, D. R. [2 ]
机构：
[1] Biogen Idec Inc, Weston, ACT, Australia
[2] Heron Evidence Dev Ltd, Luton, Beds, England
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A675 / A676
页数：2
相关论文
共 50 条
  • [1] Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis
    Mathiesen, Henrik K.
    Sorensen, Per S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1309 - 1317
  • [2] Cost-effectiveness analysis of prolonged-release fampridine to treat walking disability of multiple sclerosis in China
    Zhao, Xinran
    Yang, Han
    Wei, Tian
    Zhao, Jin
    Liu, Jun
    Huang, Zhe
    Zhu, Lin
    Zhao, Yinan
    Li, Wei
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (14) : 1057 - 1069
  • [3] Multiple sclerosis patients with severe walking disability have clinically meaningful improvements in walking speed with prolonged-release fampridine
    Hartung, H. P.
    Goodman, A.
    Putzki, N.
    JOURNAL OF NEUROLOGY, 2011, 258 : 260 - 261
  • [4] Fampridine Prolonged Release: A Review in Multiple Sclerosis Patients with Walking Disability
    Kim, Esther S.
    DRUGS, 2017, 77 (14) : 1593 - 1602
  • [5] Fampridine Prolonged Release: A Review in Multiple Sclerosis Patients with Walking Disability
    Esther S. Kim
    Drugs, 2017, 77 : 1593 - 1602
  • [6] Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern
    Zoerner, Bjoern
    Filli, Linard
    Reuter, Katja
    Kapitza, Sandra
    Loerincz, Lilla
    Sutter, Tabea
    Weller, David
    Farkas, Melinda
    Easthope, Christopher S.
    Czaplinski, Adam
    Weller, Michael
    Linnebank, Michael
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (11) : 1463 - 1475
  • [7] Response to Prolonged-Release Fampridine in Multiple Sclerosis Patients with Various Walking-Related MS Symptoms
    Short, Christine
    Putzki, Norman
    Goodman, Andrew
    NEUROLOGY, 2012, 78
  • [8] Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2012, 28 (12) : 1 - 4
  • [9] Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)
    Preiningerova, Jana Lizrova
    Baumhackl, Ulf
    Csepany, Tunde
    Czaplinski, Adam
    Deisenhammer, Florian
    Derfuss, Tobias
    Fabjan, Tanja H.
    Fazekas, Franz
    Fuchs, Siegrid
    Havrdova, Eva
    Ledinek, Alenka Horvath
    Illes, Zsolt
    Jazbec, Sasa Sega
    Klimova, Eleonora
    Komoly, Samuel
    Kurca, Egon
    Linnebank, Michael
    Lisy, Lubomir
    Mares, Jan
    Prochazkova, Lubica
    Csilla, Rozsa
    Szilasiova, Jarmila
    Stourac, Pavel
    Talab, Radomir
    Turcani, Peter
    Vachova, Marta
    Vecsei, Laszlo
    Vodusek, David
    Zapletalova, Olga
    Berger, Thomas
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (05) : 302 - 306
  • [10] Effects of prolonged-release fampridine on postural control in patients with multiple sclerosis
    Reuter, K.
    Koeszeghi, L.
    Weller, D.
    Sutter, T.
    Kapitza, S.
    Farkas, M.
    Filli, L.
    Linnebank, M.
    Zoerner, B.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 521 - 521
12345